IL109447A0 - Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis - Google Patents

Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis

Info

Publication number
IL109447A0
IL109447A0 IL10944794A IL10944794A IL109447A0 IL 109447 A0 IL109447 A0 IL 109447A0 IL 10944794 A IL10944794 A IL 10944794A IL 10944794 A IL10944794 A IL 10944794A IL 109447 A0 IL109447 A0 IL 109447A0
Authority
IL
Israel
Prior art keywords
arteriosclerosis
prophylaxis
medicament
preparation
treatment
Prior art date
Application number
IL10944794A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of IL109447A0 publication Critical patent/IL109447A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/043—Kallidins; Bradykinins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL10944794A 1993-04-29 1994-04-27 Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis IL109447A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4314073 1993-04-29

Publications (1)

Publication Number Publication Date
IL109447A0 true IL109447A0 (en) 1994-07-31

Family

ID=6486700

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10944794A IL109447A0 (en) 1993-04-29 1994-04-27 Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis

Country Status (8)

Country Link
EP (1) EP0623350A1 (no)
JP (1) JPH06312940A (no)
AU (1) AU677290B2 (no)
CA (1) CA2122429A1 (no)
HU (1) HUT66820A (no)
IL (1) IL109447A0 (no)
NO (1) NO941562L (no)
TW (1) TW301608B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2739553B1 (fr) 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
US9492495B2 (en) 2010-05-14 2016-11-15 Max-Delbrueck-Centrum Fuer Molekulare Medizin Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
EP2420245A1 (en) * 2010-08-18 2012-02-22 Max-Delbrück-Centrum Für Molekulare Medizin Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth
CN103992383B (zh) * 2014-06-27 2017-05-17 杭州阿诺生物医药科技股份有限公司 一种制备艾替班特的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3604873A1 (de) * 1986-02-15 1987-08-20 Basf Ag Verfahren zur herstellung von 2,6-bis (hydroxymethyl)-pyridin-2,6-bis-(n-methylcarbamat)

Also Published As

Publication number Publication date
JPH06312940A (ja) 1994-11-08
NO941562L (no) 1994-10-31
TW301608B (no) 1997-04-01
NO941562D0 (no) 1994-04-28
AU677290B2 (en) 1997-04-17
EP0623350A1 (de) 1994-11-09
HU9401226D0 (en) 1994-08-29
CA2122429A1 (en) 1994-10-30
AU6073794A (en) 1994-11-03
HUT66820A (en) 1995-01-30

Similar Documents

Publication Publication Date Title
GB9317171D0 (en) Surgical implants etc
HUP9903166A3 (en) Medicinal compositions for the prophylaxis or treatment of arteriosclerosis
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL119894A (en) Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis
EP0575749A3 (en) Use of potassium-channel activators for the manufacture of a medicament for the treatment of gastrointertinal ulcers
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
AU2807492A (en) Use of misoprostol for the treatment of allergy
EP0577023A3 (en) Angiotensin-ii receptor-antagonists for the treatment of arrhythmices
IL109447A0 (en) Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis
HU9303758D0 (en) Pharmaceutical composition for preventing or treating arteriosclerosis
AU4585993A (en) Use of angiotensin ii antagonists for the treatment of hyperlipidaeme
ZA916638B (en) Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type,a process for their preparation and their use as medicaments against retroviruses
ZA928198B (en) Substituted azaspiranes for use in the treatment of hyperlipidemia
GB9217124D0 (en) Medical treatment
CZ69695A3 (en) The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals
HK44597A (en) Use of chlormethiazole in the manufacture of a medicament for the prevention and/or treatment of neurodegeneration
IL105690A0 (en) Pharmaceutical compositions for the treatment of arrhythmia
IL123422A (en) USE OF 7alpha-METHYL-17alpha-ETHYNYL-ESTRANE DERIVATIVES FOR THE MANUFACTURE OF A MEDICAMENT FOR THE PROPHYLAXIS OR THE TREATMENT OF ATHEROSCLEROSIS
GB9324852D0 (en) A medicament for the treatment of metasteses
EP0460690A3 (en) Use of phenolsulfophthaline derivatives for the treatment of osteoporosis
BG98003U (en) Medicament for the treatment of dermatomycosis
EG19885A (en) Medicament for the treatment of hyperlipidaemia and/or atherosolerosis
HU9502697D0 (en) Drogs for the treatment of retrovirus infections
BG98174U (en) Preparation for hygiene of the mouth
BG98206A (en) Preparation for the treatment of morbid tumefactions of any origin